Why the study?
Pulmonary hypertension in pregnancy is linked to negative maternal and fetal outcomes, but novel treatment modalities have emerged to improve morbidity and mortality.
Contemporary multidisciplinary management and careful patient selection have significantly improved maternal mortality in pregnant women with pulmonary hypertension, though it remains a high-risk condition requiring specialized care.
Answers are grounded in this paper and cite their sources.
Supports referral to expert centers for pulmonary hypertension in pregnancy; leaves open optimal strategies pending prospective trials.
Pulmonary hypertension in pregnancy has been associated with negative maternal and fetal outcomes over the past decades. With the emergence of novel treatment modalities, morbidity and mortality of women who have pulmonary hypertension in pregnancy have improved. In this review, we aim to explore the contemporary updates in the management of pre-capillary and post-capillary pulmonary hypertension in pregnancy.
No takes yet. Share an insight, caveat, or question.
Ong et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: